Report Summary
Eternity Insights has published a new study on Global Opioids Drug Market focusing on key segments as by Type (Oxycodone,Hydromorphone,Codeine,Fentanyl,Other), by Application (Pain Relief,Anesthesia,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Opioids Drug Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Opioids Drug Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Opioids Drug Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Opioids Drug Market Segmentation:
Opioids Drug Market, By Type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
Opioids Drug Market, By Application
- Pain Relief
- Anesthesia
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Opioids Drug market in terms of demand generation. The Opioids Drug market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Opioids Drug market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Opioids Drug Market Taxonomy:
To learn more about this report
Global Opioids Drug Market Competitive Landscape
The global Opioids Drug market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Purdue Pharma
- J&J
- Teva
- Mylan
- Depomed
- INSYS
- Endo
- Pfizer
- Hikma
- Mallinckrodt
- Pernix
- Egalet
- Vistapharm
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Oxycodone,Hydromorphone,Codeine,Fentanyl,Other |
| By Application Outlook |
Pain Relief,Anesthesia,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Purdue Pharma,J&J,Teva,Mylan,Depomed,INSYS,Endo,Pfizer,Hikma,Mallinckrodt,Pernix,Egalet,Vistapharm |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Opioids Drug Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Opioids Drug Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Opioids Drug Market Performance
2.3 USA Opioids Drug Market Performance
2.4 Europe Opioids Drug Market Performance
2.5 Japan Opioids Drug Market Performance
2.6 Korea Opioids Drug Market Performance
2.7 India Opioids Drug Market Performance
2.8 Southeast Asia Opioids Drug Market Performance
2.9 South America Opioids Drug Market Performance
3 Global Opioids Drug Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Opioids Drug Market Performance (Volume)
3.3 USA Opioids Drug Market Performance (Volume)
3.4 Europe Opioids Drug Market Performance (Volume)
3.5 Japan Opioids Drug Market Performance (Volume)
3.6 Korea Opioids Drug Market Performance (Volume)
3.7 India Opioids Drug Market Performance (Volume)
3.8 Southeast Asia Opioids Drug Market Performance (Volume)
3.9 South America Opioids Drug Market Performance (Volume)
4 Competitive Analysis
4.1 Purdue Pharma
4.1.1 Purdue Pharma Profiles
4.1.2 Purdue Pharma Product Information
4.1.3 Purdue Pharma Opioids Drug Production, Revenue, Price and Gross Margin
4.1.4 Purdue Pharma Opioids Drug Business Performance
4.1.5 SWOT Analysis
4.2 J&J
4.2.1 J&J Profiles
4.2.2 J&J Product Information
4.2.3 J&J Opioids Drug Production, Revenue, Price and Gross Margin
4.2.4 J&J Opioids Drug Business Performance
4.2.5 SWOT Analysis
4.3 Teva
4.3.1 Teva Profiles
4.3.2 Teva Product Information
4.3.3 Teva Opioids Drug Production, Revenue, Price and Gross Margin
4.3.4 Teva Opioids Drug Business Performance
4.3.5 SWOT Analysis
4.4 Mylan
4.4.1 Mylan Profiles
4.4.2 Mylan Product Information
4.4.3 Mylan Opioids Drug Production, Revenue, Price and Gross Margin
4.4.4 Mylan Opioids Drug Business Performance
4.4.5 SWOT Analysis
4.5 Depomed
4.5.1 Depomed Profiles
4.5.2 Depomed Product Information
4.5.3 Depomed Opioids Drug Production, Revenue, Price and Gross Margin
4.5.4 Depomed Opioids Drug Business Performance
4.5.5 SWOT Analysis
4.6 INSYS
4.6.1 INSYS Profiles
4.6.2 INSYS Product Information
4.6.3 INSYS Opioids Drug Production, Revenue, Price and Gross Margin
4.6.4 INSYS Opioids Drug Business Performance
4.6.5 SWOT Analysis
4.7 Endo
4.7.1 Endo Profiles
4.7.2 Endo Product Information
4.7.3 Endo Opioids Drug Production, Revenue, Price and Gross Margin
4.7.4 Endo Opioids Drug Business Performance
4.7.5 SWOT Analysis
4.8 Pfizer
4.8.1 Pfizer Profiles
4.8.2 Pfizer Product Information
4.8.3 Pfizer Opioids Drug Production, Revenue, Price and Gross Margin
4.8.4 Pfizer Opioids Drug Business Performance
4.8.5 SWOT Analysis
4.9 Hikma
4.9.1 Hikma Profiles
4.9.2 Hikma Product Information
4.9.3 Hikma Opioids Drug Production, Revenue, Price and Gross Margin
4.9.4 Hikma Opioids Drug Business Performance
4.9.5 SWOT Analysis
4.10 Mallinckrodt
4.10.1 Mallinckrodt Profiles
4.10.2 Mallinckrodt Product Information
4.10.3 Mallinckrodt Opioids Drug Production, Revenue, Price and Gross Margin
4.10.4 Mallinckrodt Opioids Drug Business Performance
4.10.5 SWOT Analysis
4.11 Pernix
4.12 Egalet
4.13 Vistapharm
5 Competitive Landscape
5.1 Global Opioids Drug Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Opioids Drug Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Opioids Drug Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Opioids Drug Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Opioids Drug Market Assessment by Regions
6.1 Global Opioids Drug Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Opioids Drug Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Opioids Drug Price (USD/Unit) by Regions (2014-2020)
6.4 Global Opioids Drug Gross Margin by Regions (2014-2020)
7 Opioids Drug Regional Analysis
7.1 China Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.2 USA Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.6 India Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Opioids Drug Production, Revenue and Growth Rate (2014-2020)
7.8 South America Opioids Drug Production, Revenue and Growth Rate (2014-2020)
8 Global Opioids Drug Consumption Assessment
8.1 Global Opioids Drug Consumption and Market Share by Regions (2014-2020)
8.2 Global Opioids Drug Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Opioids Drug Average Price (USD/Unit) by Regions (2014-2020)
9 Global Opioids Drug Sales Assessment by Regions
9.1 Global Opioids Drug Sales and Sales Value (2014-2020)
9.2 China Opioids Drug Sales and Sales Value (2014-2020)
9.3 USA Opioids Drug Sales and Sales Value (2014-2020)
9.4 Europe Opioids Drug Sales and Sales Value (2014-2020)
9.5 Japan Opioids Drug Sales and Sales Value (2014-2020)
9.6 Korea Opioids Drug Sales and Sales Value (2014-2020)
9.7 India Opioids Drug Sales and Sales Value (2014-2020)
9.8 Southeast Asia Opioids Drug Sales and Sales Value (2014-2020)
9.9 South America Opioids Drug Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Opioids Drug Production and Revenue by Regions 2020-2026
12.1.2 China Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.7 India Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Opioids Drug Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Opioids Drug Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.3 China Opioids Drug Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.8 India Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Opioids Drug Sales and Sales Value Forecast 2020-2026
12.2.10 South America Opioids Drug Sales and Sales Value Forecast 2020-2026
12.3 Global Opioids Drug Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Oxycodone
12.3.3 Hydromorphone
12.3.4 Codeine
12.3.5 Fentanyl
12.3.6 Other
12.4 Global Opioids Drug Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Pain Relief
12.4.3 Anesthesia
12.4.4 Other
12.5 Global Opioids Drug Price and Gross Margin Forecast
13.5.1 Global Opioids Drug Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Opioids Drug Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
